ABSTRACT
INTRODUCTION
Dexmedetomidine is a short acting, highly lipid-soluble, selective α₂-adrenergic agonist agent which has potent sedative properties (3) . It has been demonstrated that dexmedetomidine produces antinociception in systemic (23, 28) , intrathecal (2, 29) or epidural administration (1) . It has been reported that the addition of dexmedetomidine to local anesthetic solution in intravenous regional anesthesia improved the quality of anesthesia and decreased the analgesic requirements (5, 20) . There is evidence that systemic administration of dexmedetomidine may partially prevent neuronal damage in some models of brain ischemia and this neuroprotective effect is mediated by the activation of the α₂-adrenergic receptors (8, 9, (15) (16) (17) . On the other hand, it has been shown by Konakci et al . that dexmedetomidine produced moderate or severe demyelinization of myelin sheats in the white matter of spinal cord in rabbit, when it is administered by the epidural route (14) , and this effect has been explained by the agent's vasoconstrictive effect on medullar spinal vessels (10) . It is known that topical application of dexmedetomidine had vasoconstrictor effects both on cerebral pial arterial and venous vessels (11) . Additionally, it has been reported in an experimental study that centrally administered dexmedetomidine reduced cerebral blood flow during normoxia and prevented adequate oxygen delivery during hypoxia (19) .
Establishing the safety of neuroaxial drugs is very important before these drugs are given to humans. Despite extensive use in animal experimentation, there has been no study in the medical literature about the effects of this highly liposoluble and selective α₂-adrenergic agonist anesthetic agent on cerebral neurons when administered intrathecally into the cerebrospinal fluid. The purpose of this prospective, randomized, double-blind, controlled study was to investigate whether dexmedetomidine had a toxic effect on cerebral neurons when it was administered centrally into the cerebrospinal fluid by the intracisternal route.
MATERIAL and METHODS
This experiment was performed in accordance with the guidelines for the use of laboratory animal subjects in research set by the Ethical Committee of Kirikkale University. Eighteen male Wistar rats of 250-300 gram weight were used. The rats were placed in a temperature (21 ± 2 °C) and humidity (60 ± 5 %) controlled room for one week before the experiment, a 12 h light / 12 h dark cycle was maintained, and was allowed free access to food and water before and after surgery. The animals were divided into three groups randomly which were named as follows: DIC (9 µg/kg dexmedetomidine (Precedex®; Hospira, Inc. Lake Forest, IL 60045, USA) which was diluted with 0.9 % saline administered in a volume of 0.1 ml by the intracisternal route) (n: 6), SIC (0.9 % NaCl in a volume of 0.1 ml administered by the intracisternal route (n: 6), CONTROL (no agent was administered by the intracisternal route) (n: 6).
Anesthesia was performed with intramuscular administration of 40 mg/kg ketamine HCl (Ketalar ® ; Pfizer Inc, USA) and 5 mg/ kg xylazine HCl (Rompun ® %2; Bayer HealthCare AG, Germany). Rats were kept normothermic with thermoregulatory heating unit (Harvard Apparatus) connected to the rectal probe. The right femoral artery was cannulated for continuous blood pressure monitoring (CardioCap II, Datex, Finland), and to obtain arterial blood samples. Mean arterial pressures (MAP) and heart rates (HR) were recorded during the study. Arterial blood samples were obtained at 0, 5, 15, 30 and 60 minutes to evaluate arterial carbon dioxide tension (PaCO₂), arterial oxygen tension (PaO₂), and blood pH (ABL5, Radiometer, Denmark). When the free cerebrospinal fluid flow was seen, 0.1 ml normal saline (Group SIC, n=6) or 9 µg/kg diluted dexmedetomidine in 0.1 ml volume (Group DIC, n=6) was administered within one minute from the posterior craniocervical junction of rats using a 26G needle. During the recovery period, catheters were removed. Then the animals were returned to their home cages. Twenty four hours later, all animals were re-anaesthetized with intramuscular 40 mg/ kg ketamine HCl and 5 mg/kg xylazine HCl. For sacrification, the whole body blood was collected from the vena cava inferior, and then the rats were decapitated. The brains were immediately harvested for future biochemical and histopathological examinations. All rat brains were divided into two hemispheres with a cut from sulcus centralis and then the hippocampal formations of the right hemisphere were dissected and stored in 10% buffered formaldehyde solution at room temperature for future histopathological examination. For biochemical examination, the remaining part of the right hemisphere and the plasma of the collected whole body blood were immediately stored at -30 °C in dry air.
Biochemical Analysis:
Biochemical determinations were carried out by a biochemist blinded to the animal groups and test materials. Frozen tissue samples were weighted and homogenized in 1:10 (w:v) potassium phosphate buffer (50 mM, pH:7.4) by using a dounce homogenizer. Thiobarbituric acid reactive substances (TBARS) were measured as an index of LPO by the method of Mihara et al (21, 22) . Tissue levels of lipid peroxides (as TBARS) were calculated as nanomole per gram wet tissue. Serum levels of lipid peroxides were determined by tiobarbituric acid (TBA) assay as described by Wade and van Rij, and calculated as micromole per liter (27) .
Histopathological Analysis:
For histological examination, all tissue samples were fixed at 10% buffered formaldehyde and processed according to routine light microscopic tissue processing technique. Serial coronal sections of 5 μm at the level of the hippocampus formation stained with haematoxylene-eosin were examined and photographed by an Olympus BH-2 microscope. Three random regions were examined at X 200 magnification and the number of picnotic neurons in three areas per section of hippocampal dentate gyrus (DG) region were identified and counted on the basis of the presence of picnotic nuclei and shrunken cytoplasm. Then the number of the picnotic neuronal cells was calculated as an average per rat. Each of the three sections was evaluated independently by two histologists blinded to the groups. The results of the two histologists were compared and an average was determined.
Statistical Analysis:
Data were analyzed using the SPSS 11.5 (SPSS Inc. Software, Chicago, Illinois, USA) statistical software. All data were presented as mean ± SD. Because tissue LPO levels, plasma LPO levels, histopathological data and the data of physiological parameters were normally distributed and the variations were homogenous among all groups, analyzed by using one-way analysis of variance (ANOVA) and with Tukey test as to compare the groups, and determine the differences among groups, respectively. The repeated measures of physiological parameters within different times were analyzed using general linear model analysis of variance for repeated measures. P<0.05 was considered statistically significant.
RESULTS

Physiological Parameters:
Blood gas tensions, MAP, pH and rectal temperatures were similar among all groups at all times. The repeated measures of physiological parameters within different times were also similar in all groups (Table I) .
Biochemical Analysis:
There was a statistically significant difference among all groups regarding the brain LPO levels (F=14,889, p<0.001). When posthoc comparisons were made by using Tukey Multiple Comparison Test, statistically differences were observed between the DIC/SIC groups and the DIC/CONTROL groups (p=0.002 and p<0.001, respectively) ( Figure 1 ).
There was also statistically significant difference among all groups regarding the plasma LPO levels (F=9,386, p=0.002). The mean plasma LPO levels were statistically different between the CONTROL/DIC groups and CONTROL/SIC groups (p=0.002 and p=0.047, respectively). Additionally, the mean plasma levels of the DIC group was statistically different from the SIC group (p=0.025) (Figure 2 ).
Histopathological Analysis:
There was a statistically significant difference among all groups regarding the picnotic neuronal cell counts in the hippocampus (F=28.181, p<0.001). When posthoc comparisons were made by using Tukey Multiple Comparison Test, statistically differences were observed between the CONTROL/DIC groups and the CONTROL/SIC groups (p<0.001, and p=0.001, respectively). Beside this, there was a statistically significant difference between the DIC group and the SIC group (p=0.024) (Figure 3 ). (Figure 4 ). The number of excessively degenerated picnotic neurons was especially more in the hippocampal CA3 and DG regions than in the CA1 and CA2 regions.
The histopathological findings were less severe in the SIC group than in the DIC group ( Figure 5) . The degenerated neuronal cell counts and the degree of degeneration, irregularities of intercellular organizations in the SIC group were significantly less than in the DIC group. When compared with the DIC group, the distribution of the degenerated neuronal cells in the hippocampal regions were more homogenous in the SIC and CONTROL groups. Perivascular edema was observed neither in the SCI group, nor in the CONTROL group. However, when compared with the CONTROL group, capillary stasis in some of the capillary vessels and minimal edema in some areas of neuropil were observed in the SCI group ( Figure 5, 6 ).
DISCUSSION
In order to provide ideal analgesia and anesthesia by neuroaxial route and to lessen the adverse side effects of used local anesthetics, many drugs such as opioids, benzodiazepines, magnesium, ketamine, clonidine have been used as adjuvant α₂-adrenoceptor agonists have antinociceptive effects which are in part mediated by action on spinal α₂-adrenoceptors (13, 25) . Alpha₂-adrenoceptor agonists have been used in association with local anesthetics to increase the duration of spinal anesthesia. Intrathecal or epidural administration of clonidine prolongs motor blockade induced by local anaesthetics (13, 25) . Since the affinity of dexmedetomidine to α₂-adrenoceptors is eight times greater than clonidine, it Histopathological examination of the DIC group demonstrated severe edema both at the neuropil and perivascular area. There were significant capillary stasis and perivascular edema, 
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soluble anesthetic agent, it can easily pass the blood-brain barrier when it is administered into the cerebrospinal fluid intrathecally. In this study, we aimed to investigate the possible toxic effects of dexmedetomidine on cerebral neurons when it was administered centrally into the cerebrospinal fluid by intracisternal route.
In this study, we used the lowest dose of dexmedetomidine (total dose 9 µg/kg) which is known for its neuroprotective effects by previous studies without any serious systemic adverse side effects (24, 25) . As it is possible to see the free cerebrospinal fluid flow and due to the easiness of technique, we preferred to administer the agents used in the study into cisterna magna by an injection from posterior craniocervical junction of the rats. Due to the fact that cerebrospinal fluid pressure of rat is very low and aspiration with using negative pressure might be harmful, we did not aspirate any cerebrospinal fluid before the administration of intracisternal drug. However, it was thought that the administered 0.1 ml additional volume within one minute might produce harmful effect on neuronal structures by increasing cerebrospinal fluid pressure. The SCI group which was 0.1 ml 0.9% NaCl given within one minute by intracisternal route was added to the study for the observation of this possible additional harmful effect.
Kuhmonen et al. reported in their study that there were differences in the number of surviving neurons between the various hippocampal subfields after the dexmedetomidine treatment and this condition might be related to differences in their anatomic connections. They explained these regional differences by the relative distribution and terminal fields of noradrenergic fibers within the different subfields of the hippocampus (16) . The noradrenergic afferents arising from the locus cerulous form a dense network within the hilus of the DG and in the stratum lucidum of the CA3 area (26) . However, the noradrenergic input to the CA1 subfield is less extensive and terminates largely in the stratum lacunosum moleculare. Therefore, they concluded that any therapeutic treatment that targets noradrenergic systems would be more potent in the hilus and in the CA3 subfield than in the CA1 region of the hippocampus. Hence, the picnotic neuronal cell counts were made in the hippocampal DG region in this study.
In the DIC group, the mean value of the number of the picnotic neuronal cells in the hippocampal DG region was significantly higher than in the SIC and the CONTROL groups. When compared with the DIC group, the distribution of the degenerated neuronal cells in the hippocampal regions were more homogenous in the SIC and CONTROL groups. To be compatible with the study reported by Kuhmonen et al., the histopathologic changes were more severe in the hippocampal CA3 and DG regions than in the CA1 and CA2 regions in the DIC group. This result may be explained by the presence of a dense noradrenergic input in the DG and CA3 regions of hippocampus (26) .
Adrenergic receptors are found on cerebral vessels of all sizes throughout the brain (24) , supporting the possibility of a direct vascular mechanism for the cerebral blood flow is expected that dexmedetomidine could be advantageous in regional anaesthesia (13, 18, 25) . Additionally, it has been reported that dexmedetomidine added to local anesthetics in intravenous regional anesthesia improved the quality of anaesthesia (5, 20) and it could partially prevent neuronal damage in some models of ischemia-induced brain injury (8, 9, 15-17). On the other hand, Konakci et al. reported that dexmedetomidine produced moderate or severe demyelinization of myelin sheats in the white matter of spinal cord in rabbit, when it was administered by the epidural route (14) . Because dexmedetomidine is a highly lipo- 
when it was administered centrally into the cerebrospinal fluid by histopathological and biochemical evaluations all animals were decapitated after 24 hours from the intracisternal drug administration. Although it is known that the hippocampus plays important roles in the consolidation of information from short-term memory to long-term memory and spatial navigation and there were animal studies which have been shown that an intact hippocampus is required for initial learning and long-term retention of some spatial memory tasks (30-33), we did not perform the tests related with hippocampal functions which were required more longer study and evaluation period than 24 hours. Additionally, this study did not contain observations of neurologic outcome and of functional outcome data and histopathological and biochemical evaluations occurring in the long run.
In conclusion, dexmedetomidine had a toxic effect on cerebral neurons when it was administered centrally into the cerebrospinal fluid by the intracisternal route. Although the effect mechanism and/or mechanisms are not clear, this neurotoxic effect of dexmedetomidine can be attributed to a direct vasoconstrictive effect mediated by cerebral vascular α₂-adrenergic receptors. In order to administer this highly lipo-soluble, selective α₂-adrenergic agonist by intrathecal route as a safe adjuvant agent, further studies using advanced pathologic investigations are required. effects of centrally administered α₂-adrenergic agonists. It was reported in an in vivo experimental study that topical application of dexmedetomidine had vasoconstrictor effects both on cerebral pial arterial and venous vessels (11) . Since this vasoconstrictive effect could be blocked by α₂-adrenergic antagonist agent yohimbine, the dexmedetomidine-induced vasoconstriction was attributed to the activation of the vascular α₂-adrenergic receptors. Additionally, it was shown in another experimental study that, ventricular-coeternal perfusion of dexmedetomidine resulted in widespread cerebral blood flow reduction either normoxic or hypoxic conditions (19) . Konakci et al. were shown in their study that dexmedetomidine produced the moderate or severe demyelinization of myelin sheaths in the white matter of spinal cord, when it was administered by the epidural route. They suggested that this effect could be related to vasoconstriction of the medullary spinal vessels (14) . However, they did not evaluate the possible toxic effects of dexmedetomidine on cerebral neuronal cells when it was administered by epidural route. Iida et al. reported that cerebral vessels were more sensitive to the α₂-adrenergic stimulation than the spinal counterparts (10) . Hence, we thought that the toxic effect of centrally administered dexmedetomidine into the cerebrospinal fluid by intracisternal route on cerebral neurons might be resulted from a direct vasoconstrictive effect mediated by cerebral vascular α₂-adrenergic receptors.
The picnotic neuronal cell count in the SCI group was significantly more than the CONTROL group. This situation was contributed to the produced increase in the cerebrospinal fluid pressure resulted from the additional injection of 0.1 ml volume of normal saline into the cerebrospinal fluid.
As a biochemical indicator of cerebral cellular damage, both the mean value of the brain tissue LPO levels and the mean value of the plasma LPO levels was significantly higher in the DIC group than the SIC and CONTROL groups. These biochemical results were compatible with the histopathological results of this study.
Another explanation for the neurotoxic effect of centrally administered dexmedetomidine can be made by the low pH value of the agent. Dexmedetomidine is supplied as an isotonic solution with a pH of 4.5-7. However, it is known that, clonidine, which has a similar pH of 5-7 does not exert any neurotoxic side effects (28, 29) . Additionally, since the solution is preservative-free and contains no additives or chemical stabilizer, we did not think that the neurotoxic effect of centrally administered dexmedetomidine could be related to additives, chemical stabilizers or its low pH.
This prospective experimental study has some pitfalls. Firstly, this study could not be supported by immunohistochemical, and electron microscopic findings. Secondly, because the study was designed as a short-term, preliminary study, and the main aim the study was to investigate whether dexmedetomidine had a toxic effect on cerebral neurons
